No Data
No Data
Express News | The Innovative Drugs Concept was active at the beginning of trading, with Staidson rising over 15%.
Hehua Co., Ltd.: Report for the first quarter of 2025
Guangxi Hechi Chemical (000953.SZ) turned a profit of 1.362 million yuan in the first quarter.
Gelonghui reported on April 28 that Guangxi Hechi Chemical (000953.SZ) announced its first-quarter report for 2025. During the reporting period, the company achieved revenue of 40.8331 million yuan, a decrease of 34.05% year-on-year; the net income attributable to shareholders of the listed company was 1.362 million yuan, compared to a loss of 1.16 million yuan in the same period last year; the net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 1.2438 million yuan, compared to a loss of 1.2156 million yuan in the same period last year, with basic earnings per share of 0.0037 yuan.
Hehua Co., Ltd.: 2024 Annual Report
Hehua Co., Ltd.: 2024 Annual Report Summary
The price of Vitamins D3 has surged! The Sector responded with a breakout, and Hunan Er-kang Pharmaceutical hit the 20% limit up.
Institutions: It is expected that the domestic Vitamins share will continue to increase.